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Objectives: To develop and validate an instrument assessing well-being associ-
ated with food and eating habits in a general healthy population, suitable for future 
food allegation support. Providing well-being and maintaining good health are two 
main objectives subjects seek from their diet. To date validated questionnaires 
measuring well-being in the specific context of food in general population do not 
exist. MethOds: Thorough standardized methodology was followed. Qualitative 
data from 24 discussion groups conducted with healthy subjects (n= 102) and sub-
jects with digestive, joint or immunity complaints (n= 96) served to develop the 
core of the Well-Being related to Food Questionnaire (Well-BFQ). Preliminary vali-
dation was conducted with 444 subjects with balanced diet (n= 81), non-balanced 
diet (n= 65), or standard diet (n= 298). Principal component analyses (PCA) and 
exploratory factor analyses were performed sequentially to reduce the number 
of items and determine the questionnaire structure. Confirmatory factor analyses 
with multi-trait analyses were carried out to confirm its structure. Results: The 
validated structure of the Well-BFQ has a modular backbone composed of “Grocery 
shopping”, “Cooking”, “Dining places”, “Commensality”, “Eating and drinking” and 
“Eating habits and health”. Each module is measured in terms of food behaviour 
and benefits: immediate, (Pleasure, Security, and Relaxation); direct and short term 
(Digestion and Satiety, Energy and Psychology); deferred (Metabolism, Mood and 
energy, Ageing, Bowel movement, Immunity and Mobility). PCA defined 33 interpret-
able subscales and 15 single items. Internal consistency reliability of dimensions 
was very good (Cronbach’s alpha: 0.75-0.95). Item convergent validity and divergent 
validity were moderate to excellent. cOnclusiOns: The Well-BFQ is unique to 
assess the full picture of well-being related to food and eating habits in terms of 
immediate, direct and short and deferred benefits in general population. Its modular 
structure allows interdisciplinary users to address their specific research (including 
experimental, cross-cultural comparison studies) needs by selecting the module(s) 
relevant to their objectives.
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Objectives: There is a need for a standardised method for measuring patients’ 
perceived benefit of medical devices. Currently available instruments are either 
too crude, or applicable only to a specific disease or product. Our objective was to 
develop a general instrument that measures preference-based patient benefit of 
medical devices, applicable in health economic assessments of any type of medi-
cal device used by patients with any type of disease/disability. MethOds: The 
development of the instrument followed standard qualitative and quantitative 
procedures. Interviews with health care personnel within a wide range of disease 
areas were conducted. General attributes of patient benefit with relevance for vari-
ous diseases and for various medical devices were identified from the interviews. 
To refine and test the instrument, these general attributes were validated among 
health care personnel, patient organizations, manufacturers of medical devices, 
and in two pilot studies (n= 119, n= 260) in the general population. In the final 
step, questionnaires are administrated to a sample of the general Swedish popu-
lation and analysed using a statistical weighting algorithm to assess the relative 
importance of each attribute. Results: The development process resulted in an 
instrument including 24 general attributes related to patient’s perceived benefit 
of medical devices within the following domains: sense of security, social par-
ticipation, integrity, convenience and useability. Preliminary results indicate that 
the attributes with highest preference concern reliability, and sense of control of 
the disease/disability. Facilitation of overnight travelling and storage convenience 
are considered less important. Attributes concerning social acceptability are of 
higher importance to younger than to older persons, while simplicity in using the 
device is more important to older persons. cOnclusiOns: A novel instrument for 
measuring patient benefit of medical devices has been developed. This instrument 
may be used in health economic assessments of various medical devices used in 
a wide range of diseases.
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Objectives: Despite EQ-5D’s long establishment, valuation methods have only 
in recent times been subjected to fresh consideration, mainly driven by the intro-
duction of EQ-5D-5L. However, methods in relation to modelling of health states 
not directly valued have undergone less change. This work uses the Irish 3L data 
set to test a number of alternative methods for the 3L sets. MethOds: Existing 
methods employed for valuation studies include fitting logistic regression mod-
els to the data. The addition of interaction terms to capture any extreme health 
problems (N3), moderate levels (D2), and others, has predominated. Using TTO, 
a respondent may trade off at some unknown point between two given figures. 
health related information. Results: Of the 3,571 individuals 2,593 were employed 
and 978 unemployed, among the latter 27,6% because of health reasons. As con-
sequences of health disturbances 4.9% of the individuals in the employed group 
could not work any longer in their learned profession, 9.3% could not perform all 
elements of their jobs, 11.4% had to take breaks more often and 4.1% needed special 
tools for compensate of their handicaps. These four items were combined with 
the sick leave information into an “Occupational Disability Index (ODI)”. Reliability 
analysis resulted in Cronbach’s alpha of .66 which is fairly satisfactory for a five-
item index. The ODI correlated well with health measures: General Health (SF-36) by 
r= .356 (p< .000), Functional Limitation (SF36) r= .398 (p< .000); as well as with meas-
ures of social and economic life-quality: Satisfaction with work r= -.261 (p< .000), 
Satisfaction with life as a whole r= -.277 (p< .000) and Satisfaction with income 
r= -.163 (p< 000). cOnclusiOns: The short five-item “Occupational Disability Index” 
has satisfactory psychometric properties. It can be used to analyse the impacts of 
diseases on work performance and/or the need for rehabilitation measures.
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Objectives: An online survey was conducted with neurologists to understand 
how they assess multiple sclerosis (MS) during typical office visits. This informa-
tion was gathered to support the possible development of outcome measures for 
patients with MS. MethOds: A web-based survey was conducted with neurolo-
gists in the United States (US), United Kingdom (UK), Germany, and Sweden in 
April and May 2015. The survey asked about neurologists’ professional background; 
perceptions of important symptoms and impact; and assessment methods used 
for each domain. Results: A total of 72 neurologists (26 US; 25 UK; 11 Germany; 
10 Sweden) completed the survey, including general neurologists (n= 19; 26.4%) 
and neurologists specializing in MS (n= 53; 73.6%). The following signs/symptoms 
of MS were considered important to assess in every or most office visits by ≥ 75% 
of the sample: walking/gait issues (87.%), fatigue/exhaustion/tiredness (81.9%), 
pain (80.6%), bladder (79.2%), coordination (79.2%), weakness (79.2%), balance 
(77.8%), vision (77.8%), cognition (77.8%), spasticity (77.8%), and mood/emotions 
(75.0%). Areas of impact most commonly identified as important to assess during 
office visits included mobility (91.7%), activities of daily living (84.7%), independ-
ence (84.7%), work (84.7%), self-care (77.8%), sleep (76.4%), and social function-
ing (75.0%). Across all signs, symptoms, and areas of impact, the most common 
assessment approaches were asking the patient a direct question, the neurologi-
cal exam, and informal observation of the patient. Performance-based measures 
were used less frequently, most commonly to assess walking (by 23.6% of the 
sample). Standardized clinician-reported (ClinRO) and patient-reported outcomes 
(PRO) instruments appear to be used rarely, but most commonly for assessment of 
cognition (12.5%). cOnclusiOns: Neurologists reported that MS symptoms are 
typically assessed via general questions, a neurological exam, and direct obser-
vation. According to this sample, standardized measurement approaches are not 
commonly used. A brief clinician-reported measure of MS symptoms and impact 
could help standardize and quantify these assessments.
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Objectives: Dyspnea is a major issue for patients suffering from respiratory dis-
eases. The MDP questionnaire was developed as a tool to evaluate both the sensory 
and emotional dimensions of dyspnea. The MDP still needed to be validated in a 
clinical setting context. The aim of this study was to validate the psychometric 
properties of the MDP. MethOds: A prospective, multicenter and observational 
study was conducted in patients with chronic obstructive pulmonary disease 
(COPD) at three times of assessment (inclusion visit, 3 and 3.5 months after) in 
France. The MDP includes 11 items (1: unpleasantness; 5: sensory dimension and 
5: emotional dimension) to compute the immediate perception score (sensory and 
unpleasantness items) and the emotional score (emotional items). The construct 
validity (using multi-trait), the concurrent and clinical validity (tested by com-
parison with MMRC, CAT, SF-12, DIRECT, K6, MCS, HADS and clinical parameters), 
internal consistency reliability and test-retest reliability allowed assessing the 
psychometric properties of the MDP. Results: The main population included 
276 patients (mean age= 58, 78.4% male) with COPD at different severity stages. 
All sensory and emotional items met both convergent and discriminant valid-
ity criteria, confirming the structure of the questionnaire. Psychometric scores 
matched standards for clinical validity (the worse the health status of the patient, 
the worse the scores; more impacted from GOLD stage II to IV and from MMRC 
grade 3 to 4), concurrent validity (majority of correlations between 0.40 and 0.70), 
internal consistency reliability (Cronbach’s alpha= 0.89 and 0.82 for sensory and 
emotional dimensions, respectively) and test-retest reliability (intraclass corre-
lations= 0.84 and 0.86 for immediate perception and emotional scores, respec-
tively). cOnclusiOns: The MDP questionnaire is a valid and reliable instrument 
to measure both sensory and emotional dimensions of dyspnea perceived by COPD 
patients in a clinical setting context. Further studies will be necessary to evaluate 
the responsiveness of the questionnaire.
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Objectives: Identify the make-up of the Spanish-speaking population in the United 
States; assess the impact of immigration on language; analyse issues faced dur-
ing linguistic validation of Clinical Outcomes Assessments (COA). MethOds: We 
investigated population numbers of native-Spanish speakers in the US; researched 
statistics regarding country-of-origin; reviewed linguistic validation projects for the 
U.S. and Latin America (LATAM); compared the results. Results: The 2010 census 
revealed that 16% of the U.S. population were of Hispanic or Latino origin, with 13% 
of children under five years old speaking a form of Spanish at home. We discovered 
that the distribution of Spanish speakers varies according to country of origin, with 
pockets of high densities. For example, regionally, the South is home to the majority 
of South American Hispanics (42%), the West is home to 51% of Mexicans, and the 
Northeast has welcomed over three quarters of Dominican Republicans in the U.S.. 
Hispanics of Mexican origin have the highest population of Spanish-speakers in the 
U.S. but those of South American and other Central American origins have markedly 
increased since 2000. There are significant differences in terminology used across 
Spanish-speaking populations. One example of this variation is the use of ‘once 
every other day’, a common instruction for COA or medication administration. The 
various translations used LATAM included ‘one day yes and one day no’, ‘take once 
a day on alternating days’ and ‘every third day’. This diversity demonstrates the 
number of influences on the U.S. Spanish language due to the varied population, but 
is only the tip of the iceberg. cOnclusiOns: We recommend that, during linguistic 
validation, a specific translation is developed for use in the U.S. by working with 
linguists from a range of LATAM countries. This will ensure a neutral translation is 
created that will be acceptable to the diverse range of Spanish-speaking individu-
als throughout the U.S.
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Objectives: Our study aims to investigate any additional domain more specific to 
Asian countries while retaining the existing domains of EQ-5D centered on Western 
society. After identifying candidate domains, we examined the level of health in a 
general population and compared the results from EQ-5D with additional domains 
and the ones from original EQ-5D. MethOds: We organized candidate domains 
that could be included in the preference-based HRQoL instrument after reviewing 
the HRQoL measures and conducted focus group discussion (FGD) targeting the 
general public. To examine the practicality of the HRQoL measure, we conducted the 
survey with nationally representative 1,000 adults aged 19 to 69 in Korea. In order to 
assess the influence of each domain on HRQoL, we performed quantile and logistic 
regression analyses using the visual analog scale (EQ-VAS) and self-rated health 
as a dependent variable. Results: As the result of FGD, vision, hearing, speaking, 
memory, sleep, vitality, happiness, and close relationship were established as addi-
tional measurement domains. Through survey, the mean EQ-VAS score was 80.11 
(standard deviation 12.84). Among those who did not have problems in the EQ-5D’s 
5 domains, the number of people who reported problems in vitality was 244 (37.2%), 
happiness 130 (19.8%), and sleep 71 (10.8%). Among them, the number of people who 
described their self-rated health from “good” to “poor” was as high as 76 (11.6%). 
In the quantile regression model, pain/discomfort and anxiety/depression from 
the EQ-5D domains and vision, sleep, vitality, and happiness from the additional 
domains showed statistical significance. Also, the explanatory powers increased. 
Among the additional 8 domains, the group with vitality, sleep and happiness had 
a higher probability of having good self-rated health. cOnclusiOns: Vitality, sleep 
and happiness were significant additional factors for new HRQoL domains. However, 
since many other factors may exist outside of HRQoL domains, various aspects 
should be considered when developing a new tool.
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Objectives: To assess content equivalence and usability between paper and 
electronic versions of the Psoriasis Symptom and Sign Diary (PSSD) on a hand-
held (24-hour recall) and tablet (7-day recall) among subjects with plaque pso-
riasis. MethOds: A cross-sectional, qualitative study was conducted involving 
one-on-one cognitive and usability interviews in US adults with physician-con-
firmed plaque psoriasis. Each participant completed the 24-hour version on paper 
and handheld and the 7-day version on paper and tablet, before being interviewed. 
Participants were randomized to order of recall period and mode administration. 
Interviews were conducted in two rounds with revisions made to both devices 
between rounds. Results: The mean age of sample (N= 14) was 51 (range: 32 to 
73 years); 57% were female. The majority (n= 12, 86%) reported positive overall 
impressions of the handheld and tablet, finding them easy to use and more con-
venient than paper. Participants also found the PSSD content similar between 
versions. In Round 1, all participants (n= 7) suggested increasing the size of the 
NRS scale, questions or instructions on the handheld; 4 participants selected a 
different response than intended due to small scale size. For the tablet, suggestions 
included increasing the font size and highlighting selected responses. As a result 
of Round 1, the font size of the PSSD was increased on the handheld, the tablet 
was updated to highlight the response selected in a different color, and additional 
We have applied an interval regression model to ensure that the results take 
into account such uncertainty. Further we have employed latent variable mod-
els to identify subgroups of respondents within the dataset. A reference group 
can then be identified, rather than excluding respondents according to arbitrary 
decision rules. Results: A latent variable approach was found to accommodate 
heterogeneity in the respondent cohort, providing better sensitivity compared 
to medians (which might otherwise be expected to fulfil a similar role). Interval 
regression (both log-normalised and otherwise) appears to have only had a small 
impact on the subsequently derived quality of life in each health state, though it 
may be considered a more accurate result. The log-normalised interval regression 
approach also reduced the effect of extreme WTD scores. cOnclusiOns: We have 
explored alternative statistical techniques for tackling some of the challenges 
associated with TTO data. The use of simple regression analysis may not neces-
sarily be the most accurate reflection of population preferences. Techniques such 
as interval regression and latent variable models should be further investigated in 
future.
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Objectives: The aim of this study is to develop and nourish a discrete choice experi-
ment according to the conjoint-analysis systematic development procedures that 
would allow assessing patients’ and professionals’ preferences for the characteristics 
of home enteral nutrition (HEN) via tube feeding, and the concordance of answers 
between patients and their caregivers in Spain. MethOds: Different attributes and 
levels were extracted from the published literature and presented to two focal groups 
formed by patients receiving HEN (n= 5) and HEN experts (n= 6). Both groups were 
asked to identify which attributes and levels were relevant when choosing a HEN 
product, according to their personal or professional experience. In addition, the focal 
group of patients had to assess if the drafting of those attributes and levels would 
be intelligible for other patients. A fractional factorial analysis using the support.CEs 
package for the statistical software R was performed to define the scenarios that 
would be used on the questionnaire. Results: From all the characteristics presented 
to focal groups, participants identified 6 attributes as relevant, including 2 levels 
each: TOLERANCE (easily/hardly tolerable), ADAPTATION TO COMORBIDITIES (adapt-
able/not adaptable to other present comorbidities), NUTRIENTS AND CALORIES (pro-
vides/does not provide the nutrients and calories needed by the patient), CONTAINER 
CHARACTERISTICS (its characteristics make easier/harder to handle the packaging), 
CONNECTIONS BETWEEN THE CONTAINER AND THE FEEDING TUBE (product con-
nections are easy/hard to perform) and INFORMATION (the container includes/does 
not include information about the nutrient composition and branding). From the 64 
possible scenarios, the fractional factorial analysis generated 8 sets of choices that 
fulfilled the properties of orthogonality and balance. cOnclusiOns: The first steps 
of the conjoint-analysis systematic development procedure, has allowed to describe 
the final HEN characteristic of importance for patients and professionals that later 
on will produce each scenario utility values.
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Objectives: ASCEND is a phase 3, randomized, double-blind, placebo-controlled 
trial assessing whether natalizumab slows disability progression in SPMS. The 
objective of this study was to carry out an empirical post-hoc analysis of ASCEND 
blinded baseline data to equate items from the Multiple Sclerosis Walking Scale 
(MSWS-12), Multiple Sclerosis Impact Scale (MSIS-29), ABILHAND-56, and Short-
Form 36 (SF-36) in order to provide a clearer understanding of the relationship 
between their respective items on “Physical” and “Psychosocial” impact meas-
urement continua. MethOds: MSWS-12, MSIS-29, ABILHAND-56, and SF-36 
data from 889 patients were combined based on a predefined conceptual frame-
work (contrasting broad domains of physical and psychosocial impact). Rasch 
Measurement Theory (RMT) analyses were performed on the equating item banks 
using RUMM2030 software to examine: scale-to-sample targeting, item fit, local 
dependency, and reliability. Results: The ‘Physical Impact’ item bank showed 
adequate scale performance except for some reversed thresholds (5 of 92) and mis-
fit (5 of 92 fit residuals; 20 of 92 Chi-square). Relative item locations implied that, 
in general, lower limb related items represent the less impacted end of the con-
tinuum followed by upper limb related items; general limitations items tended to 
sit in the middle of the measurement continuum. The ‘Psychosocial Impact’ item 
bank performed psychometrically well, except for some misfit (7 of 15 fit residuals; 
2 of 15 Chi-square). Relative item locations implied that ‘worries’ and ‘anxieties’ 
are at the less impacted end of the continuum followed by ‘mood’ and ‘depression’ 
items. These findings are consistent with clinical expectation. cOnclusiOns: 
Psychometrically, the ‘Physical Impact’ and ‘Psychosocial Impact’ equating item 
banks proposed have strong measurement properties. However, issues related 
to response options and item fit still require consideration (in both banks), and 
coverage could still be improved in the ‘Psychosocial Impact’ equating bank due 
to the relatively small number of items.
